Vivoryon Therapeutics N.V.
VVY.ASHealthcareLEI 3912004AMB0KGZXZYJ15
This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings for this company, out of 7. Reading the whole list, and the filer page behind every line, is part of the subscription. So are the insider, quant and timing scores for this company, the price beside each line, the price history with every buy marked on it, the moments when several insiders bought within ninety days, and following this company. What that costs is on the pricing page.
The most recent filings
5 of 7Most recent trade first. Reported is the day the filing reached the AFM, usually a few days after the trade itself, so that column runs slightly out of step. On an award the register reports a price of 0: nothing was paid, and the Quantity column shows the size.
| Filed by | Transaction | Reported |
|---|---|---|
| Irsfeld M.CFO | Awardnothing paidquantity 60,000 | Apr 22, 2026 |
| Irsfeld M.CFO (not formally appointed as director within the meaning of Dutch Corporate law) | Awardnothing paidquantity 20,000 | Oct 21, 2025 |
| Gocalves Cacela Matias S.CEO | Open-market buy€83,740quantity 10,600 | Nov 7, 2023 |
| Weber F.Chief Medical Officer | Awardnothing paidquantity 180,000 | Aug 9, 2023 |
| Weber F.Chief Medical Officer | Awardnothing paidquantity 90,000 | Aug 9, 2023 |